MAAT INDEX

CLAIM #33350 · Intuitive Surgical Inc (ISRG) · 2025Q4 earnings call · Jan 22, 2026 · due Dec 31, 2026

In 2026, da Vinci 5 capabilities will continue to grow as we introduce additional products and features.

Dave Rosa · CEO

PENDING
graded after results covering Dec 31, 2026 are reported

How to check this claim

Look at: Number of new da Vinci 5 product or feature releases (e.g., new instruments, software updates, clearances) disclosed by the company in 2026

It came true if: At least 1 new da Vinci 5 product/feature/clearance announced or launched during 2026

Where: Company press releases, quarterly earnings calls, and 10-K/10-Q disclosures during fiscal year 2026

In context

ted to fully launch our Force Feedback instruments and work with customers to establish the clinical impact of Force Feedback at scale. This month, we received FDA clearance for several cardiac procedures on da Vinci 5 using non-Force Feedback instruments. Given the complexity of minimally invasive cardiac surgery, we are planning a measured rollout to support training, education and adoption. We believe deeply that patients requiring cardiac surgery can benefit from a minimally invasive approach with da Vinci and look forward to actively supporting our customers through these procedures. Over the past year, we released 2 software updates that improve surgeon awareness in the console, supported better intraoperative decision-making and established the foundation for future remote updates. In 2026, da Vinci 5 capabilities will continue to grow as we introduce additional products and features. My Intuitive+, our digital subscription package offered with da Vinci 5 includes simulation, telecollaboration and case insights and is designed to help customers understand their surgical performance, collaborate in real time and receive personalized training recommendations. Adoption of our Telepresence capabilities continues to increase, supported by recent software changes that enable surgeon-initiated scheduling. Surgeons are now able to more easily tap into the collective knowledge of the da Vinci community through real-time case observation, collaboration and mentoring. Increasingly, we are hearing from IDN executives that they value the ability to connect flagship hospitals within their broader network to provide consistent high-quality care to more patients. Our single-port platf

Verify independently

SEC filings for ISRG · Claim quote is verbatim from the 2025Q4 earnings call.